{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP03667",
    "Peptide Name": "Clavanin AK (synthetic AMPs, UCLL1)",
    "Source": "amino acid substitution, invertebrate, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "VGQFLGKIIKKVGNFVKGFSKVF",
    "Sequence Length": 23,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Anti-MRSA"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": -0.14,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "48%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals this sequence is most similar (78.26%) toClavanin AR=W: 33%; G=N: 17%.  GRAVY: -2.45; M Wt: 2585.889; Mol formula: C120H170N42O22; molar extinction coeff: 33300.Activity: active against Gram+ S. aureus 930918-3 or 30371 MRSA or 28841 MRSA (MIC 2.5-5.8 ug/ml), E. faecalis CDC 21 (MIC 2.6 ug/ml), E. faecium 94-132 (MIC 0.3-0.5 ug/ml), L. monocytogenes EGD (MIC 0.4 ug/ml), Gram- E. coli ML-35p or mcr 106 or  BAS 849 (MIC 0.4-2.3 ug/ml), S. typhimurium 14028S or 7953S (MIC 1.3-1.5 ug/ml), K. pneumoniae 2270 (MIC 2.8 ug/ml), P. aeruginosa SBI-N or MR2123 or MR3007 (MIC 0.7-0.9 ug/ml).Antimicrobial robustness: its activity is less sensitive to salts than the WT till 300 mM:  NaCl-insensitive:E. coli.",
    "Author": "Lee IH, Cho Y, Lehrer RI. 1997",
    "Reference": "Infect Immun. 1997 Jul;65(7):2898-903. doi: 10.1128/iai.65.7.2898-2903.1997.Pub-Med.",
    "Title": "Effects of pH and salinity on the antimicrobial properties of clavanins."
  },
  "3D Structure": []
}